tradingkey.logo
tradingkey.logo
Search

Protagonist Therapeutics Inc

PTGX
Add to Watchlist
136.640USD
-2.000-1.44%
Close 07-31 16:00ETQuotes delayed by 15 min
8.79BMarket Cap
LossP/E TTM

PTGX Financials

See Protagonist Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Protagonist Therapeutics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
0.06/-0.53
Revenue / Forecast
56.37M/16.27M
Period
FY2025 Earnings
Revenue(YoY)
46.02M
-89.41%
EPS(YoY)
-2.05
-145.80%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
131.40%0.06
-132.81%-0.69
-14.73%-0.62
-9.63%-0.55
-105.43%-0.19
366.96%2.11
6.70%-0.54
26.28%-0.50
610.92%3.41
165.16%0.45
---0.58
---0.68
---0.67
---0.69
---1.90
----
----
----
----
----
Revenue
99.03%56.37M
-95.64%7.44M
0.79%4.71M
33.09%5.55M
-88.89%28.32M
184.40%170.64M
--4.67M
--4.17M
--254.95M
--60.00M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-62.08%859.00K
315.61%25.72M
52.51%8.62M
-21.56%10.29M
-63.57%2.27M
Net Profit
132.46%3.78M
-133.71%-44.38M
-18.46%-39.34M
-13.57%-34.77M
-105.62%-11.65M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
179.94%27.34M
-9.20%-34.10M
6.28%-38.46M
-61.13%-33.73M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
12.78%-20.93M
-95.42%-36.91M
-335.45%-33.80M
-58.81%-30.84M
Net Margin
116.31%6.71%
-873.40%-596.80%
-17.53%-834.87%
14.67%-626.96%
-150.60%-41.15%
69.38%77.17%
---710.37%
---734.73%
--81.32%
--45.56%
----
----
----
----
---350.62%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
--100.00%
----
----
----
----
----
Debt to assets ratio
----
--0.00%
----
----
----
--0.00%
----
----
----
--0.00%
----
----
--0.00%
--0.00%
----
----
----
----
----
----
Revenue
99.03%56.37M
-95.64%7.44M
0.79%4.71M
33.09%5.55M
-88.89%28.32M
184.40%170.64M
--4.67M
--4.17M
--254.95M
--60.00M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-62.08%859.00K
315.61%25.72M
52.51%8.62M
-21.56%10.29M
-63.57%2.27M
Operating profit
81.11%-3.65M
-139.72%-50.35M
-11.98%-46.42M
-8.37%-42.04M
-109.36%-19.31M
450.05%126.78M
-8.16%-41.45M
8.41%-38.79M
672.75%206.31M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
1.35%-36.52M
4.78%-32.30M
-34.20%-41.44M
12.11%-21.11M
-96.58%-37.02M
-336.52%-33.93M
-69.52%-30.88M
Net Profit
132.46%3.78M
-133.71%-44.38M
-18.46%-39.34M
-13.57%-34.77M
-105.62%-11.65M
381.70%131.67M
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
179.94%27.34M
-9.20%-34.10M
6.28%-38.46M
-61.13%-33.73M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
12.78%-20.93M
-95.42%-36.91M
-335.45%-33.80M
-58.81%-30.84M
Current assets
1.25%613.46M
-2.38%577.57M
23.00%586.42M
5.54%602.53M
-3.46%605.86M
66.39%591.64M
46.75%476.77M
80.14%570.92M
166.21%627.55M
46.28%355.58M
17.45%324.88M
4.15%316.94M
-30.97%235.74M
-28.66%243.08M
-15.58%276.62M
-18.16%304.30M
19.62%341.52M
7.96%340.74M
60.51%327.69M
70.98%371.82M
Total current liabilities
-1.60%34.55M
-4.13%45.44M
0.82%44.94M
-14.60%35.51M
-12.02%35.11M
122.80%47.40M
59.97%44.58M
57.50%41.58M
71.81%39.91M
-31.77%21.27M
-24.18%27.87M
-34.15%26.40M
-46.55%23.23M
-29.16%31.18M
-6.13%36.75M
-6.71%40.09M
25.90%43.46M
9.38%44.02M
1.54%39.16M
21.53%42.97M
Total assets
-6.02%697.46M
-10.28%668.19M
16.20%701.69M
16.82%718.01M
17.93%742.13M
108.05%744.73M
82.98%603.86M
91.79%614.63M
162.35%629.28M
44.38%357.95M
16.95%330.02M
3.21%320.47M
-31.13%239.86M
-28.69%247.93M
-24.39%282.17M
-23.18%310.51M
16.85%348.30M
7.16%347.69M
71.72%373.18M
79.67%404.23M
Total liabilities
-20.90%41.99M
-22.97%53.48M
-21.81%56.25M
-31.81%49.99M
-22.88%53.08M
226.36%69.43M
158.16%71.94M
177.69%73.31M
190.54%68.83M
-34.18%21.27M
-27.73%27.87M
-37.94%26.40M
-49.07%23.69M
-32.21%32.32M
-11.39%38.56M
-9.09%42.53M
20.08%46.52M
6.27%47.67M
-8.83%43.52M
-18.63%46.78M
Total equity
-4.87%655.47M
-8.97%614.71M
21.34%645.44M
23.40%668.02M
22.95%689.05M
100.58%675.29M
76.04%531.91M
84.08%541.32M
159.26%560.44M
56.15%336.68M
24.03%302.15M
9.74%294.07M
-28.37%216.17M
-28.14%215.61M
-26.10%243.62M
-25.03%267.98M
16.37%301.78M
7.30%300.02M
94.39%329.66M
113.42%357.45M
Net operating income
-139.04%-48.94M
-26.72%-36.98M
93.05%-1.94M
-110.71%-28.78M
557.05%125.36M
-272.04%-29.18M
-4.70%-27.86M
1123.79%268.62M
20.14%-27.43M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
-17.43%-31.64M
11.48%-25.20M
42.47%-13.63M
-30.98%-37.67M
-42.78%-26.94M
-74.80%-28.47M
-10.32%-23.70M
Net investment
196.28%90.89M
659.48%48.81M
71.94%-58.55M
162.20%54.81M
-1654.97%-94.40M
85.76%-8.72M
-1439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-1657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
-85.88%3.94M
228.11%57.27M
346.85%34.73M
34.11%-4.48M
137.45%27.87M
17.40%-44.71M
250.32%7.77M
Net financing
104.26%23.37M
-29.62%2.84M
-53.04%5.66M
13.72%2.92M
58.95%11.44M
664.90%4.03M
-65.88%12.05M
-97.62%2.57M
-72.80%7.20M
-4.70%527.00K
5093.38%35.31M
15807.65%108.17M
56.35%26.46M
-74.55%553.00K
-50.76%680.00K
-99.46%680.00K
1628.80%16.93M
-98.29%2.17M
-81.99%1.38M
11.38%125.39M

FAQs

What is the total revenue of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total revenue reached 46.02M, with a year-on-year change of 434.43M.

What are the current assets of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its current assets were 577.57M, with a year-on-year change of -2.38.

What are the total assets of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total assets of Protagonist Therapeutics Inc were 668.19M, with a year-on-year change of -10.28.

What are the total liabilities of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total liabilities of Protagonist Therapeutics Inc were 53.48M, with a year-on-year change of -22.97.

What is the total equity of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its total equity of Protagonist Therapeutics Inc was 614.71M, with a year-on-year change of -8.97.

What is the net operating income of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net operating income of Protagonist Therapeutics Inc was -158.13M, with a year-on-year change of -162.54.

What is the net investment of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net investment of Protagonist Therapeutics Inc was -49.33M, with a year-on-year change of 83.53.

What is the net financing of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net financing of Protagonist Therapeutics Inc was 22.86M, with a year-on-year change of -11.56.

What is the Earnings Per Share (EPS) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.05, with a year-on-year change of -145.80.

What is the net income of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net income was -130.15M, with a year-on-year change of -147.29.

What is the net margin of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its net profit margin was -282.83, with a year-on-year change of -546.50.

What is the Return on Equity (ROE) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -20.18, with a year-on-year change of -137.10.

What is the Return on Assets (ROA) of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -18.42, with a year-on-year change of -136.91.

What is the operating profit of Protagonist Therapeutics Inc?

According to Protagonist Therapeutics Inc's FY2025 earnings report, its operating profit was -158.13M, with a year-on-year change of -162.54.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.